M. S. Anderson and J. A. Bluestone, The NOD mouse: A Model of Immune Dysregulation, Annu Rev Immunol, vol.23, 2005.

S. Ashkar, G. F. Weber, V. Panoutsakopoulou, M. E. Sanchirico, M. Jansson et al., Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity, Science, vol.287, pp.860-864, 2000.

C. Aspord, S. Rome, and C. Thivolet, Early events in islets and pancreatic lymph nodes in autoimmune diabetes, J Autoimmun, vol.23, pp.27-35, 2004.

A. G. Baxter, Immunogenetics and the cause of autoimmune disease, Autoimmunity, vol.25, pp.177-189, 1997.

A. E. Berezin and A. A. Kremzer, Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease, Atherosclerosis, vol.229, pp.475-481, 2013.

A. Bhatnagar, P. J. Milburn, M. Lobigs, R. V. Blanden, and A. M. Gautam, Nonobese diabetic mice display elevated levels of class II-associated invariant chain peptide associated with I-Ag7 on the cell surface, J Immunol, vol.166, pp.4490-4497, 2001.

N. Bissonnette, Short communication: Genetic association of variations in the osteopontin gene (SPP1) with lactation persistency in dairy cattle, Journal of dairy science, vol.101, pp.456-461, 2018.

E. M. Bradshaw, K. Raddassi, W. Elyaman, T. Orban, P. A. Gottlieb et al., Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells, J Immunol, vol.183, pp.4432-4439, 2009.

H. Cantor, T-cell receptor crossreactivity and autoimmune disease, Advances in immunology, vol.75, pp.209-233, 2000.

B. Christensen, E. Klaning, M. S. Nielsen, M. H. Andersen, and E. S. Sorensen, C-terminal modification of osteopontin inhibits interaction with the alphaVbeta3-integrin, J Biol Chem, vol.287, pp.3788-3797, 2012.

N. Clemente, C. Comi, D. Raineri, G. Cappellano, D. Vecchio et al., Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis, Frontiers in immunology, vol.8, 2017.

N. Clemente, D. Raineri, G. Cappellano, E. Boggio, F. Favero et al., Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases, Journal of immunology research, p.7675437, 2016.

B. De-gouyon, E. Melanitou, M. F. Richard, M. Requarth, I. H. Hahn et al., Genetic analysis of diabetes and insulitis in an interspecific cross of the nonobese diabetic mouse with Mus spretus, Proc Natl Acad Sci U S A, vol.90, 1993.

J. P. Driver, Y. G. Chen, and C. E. Mathews, Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes. The review of diabetic studies : RDS 9, pp.169-187, 2012.

A. M. Ercolini and S. D. Miller, The role of infections in autoimmune disease, Clin Exp Immunol, vol.155, pp.1-15, 2009.

K. Fan, J. Dai, H. Wang, H. Wei, Z. Cao et al., Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells, Arthritis Rheum, vol.58, pp.2041-2052, 2008.

A. Fierabracci, P. A. Biro, Y. Yiangou, C. Mennuni, A. Luzzago et al., Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulindependent diabetes mellitus, Vaccine, vol.18, pp.342-354, 1999.

S. G. Gao, Y. Yu, C. Zeng, S. T. Lu, J. Tian et al., Phosphorylation of osteopontin has proapoptotic and proinflammatory effects on human knee osteoarthritis chondrocytes, Experimental and therapeutic medicine, vol.12, pp.3488-3494, 2016.

H. J. Garchon, J. J. Luan, L. Eloy, P. Bedossa, and J. F. Bach, Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction, Eur J Immunol, vol.24, pp.380-384, 1994.

E. Giraud, E. Rouault, L. Fiette, J. H. Colle, D. Smirlis et al., Expression and regulation of osteopontin in type 1 diabetes, BMC microbiology, vol.19, pp.34-41, 2009.

L. Hornum, J. Romer, and H. Markholst, The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1, Diabetes, vol.51, pp.1972-1979, 2002.

E. M. Hur, S. Youssef, M. E. Haws, S. Y. Zhang, R. A. Sobel et al., Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells, Nat Immunol, vol.8, pp.74-83, 2007.

E. A. James, M. Pietropaolo, and M. J. Mamula, Immune Recognition of beta-Cells: Neoepitopes as Key Players in the Loss of Tolerance, Diabetes, vol.67, pp.1035-1042, 2018.

M. Jansson, V. Panoutsakopoulou, J. Baker, L. Klein, and H. Cantor, Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice, J Immunol, vol.168, pp.2096-2099, 2002.

A. C. Johansson, A. K. Lindqvist, M. Johannesson, and R. Holmdahl, Genetic heterogeneity of autoimmune disorders in the nonobese diabetic mouse, Scand J Immunol, vol.57, pp.203-213, 2003.

S. Jono, C. Peinado, and C. M. Giachelli, Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification, J Biol Chem, vol.275, pp.20197-20203, 2000.

A. Junaid, M. C. Moon, G. E. Harding, and P. Zahradka, Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1. American journal of physiology, Cell physiology, vol.292, pp.919-926, 2007.

B. Kaleta and A. Boguska, Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells, Archivum immunologiae et therapiae experimentalis, vol.65, pp.347-353, 2017.

A. Kamal, R. K. Darwish, S. Saad, M. Salama, T. S. El-baradie et al., Association of Osteopontin Gene Polymorphisms with Colorectal Cancer, Cancer investigation, vol.35, pp.71-77, 2017.

S. A. Khan, C. A. Lopez-chua, J. Zhang, L. W. Fisher, E. S. Sorensen et al., Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors, Journal of cellular biochemistry, vol.85, 2002.

A. C. Khodavirdi, Z. Song, S. Yang, C. Zhong, S. Wang et al., Increased expression of osteopontin contributes to the progression of prostate cancer, Cancer Res, vol.66, pp.883-888, 2006.

H. Lavi, M. Assayag, A. Schwartz, N. Arish, Z. G. Fridlender et al., The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis, PloS one, vol.12, 2017.

J. L. Lee, M. J. Wang, P. R. Sudhir, G. D. Chen, C. W. Chi et al., Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells, Cancer Res, vol.67, pp.2089-2097, 2007.

E. H. Leiter, The NOD mouse: A model for analyzing the interplay between heredity and environment in development of autoimmune disease, ILAR News, p.4, 1993.

L. Liaw, D. E. Birk, C. B. Ballas, J. S. Whitsitt, J. M. Davidson et al., Altered wound healing in mice lacking a functional osteopontin gene (spp1), J Clin Invest, vol.101, pp.1468-1478, 1998.

S. A. Lund, C. M. Giachelli, and M. Scatena, The role of osteopontin in inflammatory processes, Journal of cell communication and signaling, vol.3, pp.311-322, 2009.

S. A. Lund, C. L. Wilson, E. W. Raines, J. Tang, C. M. Giachelli et al., Osteopontin mediates macrophage chemotaxis via alpha4 and alpha9 integrins and survival via the alpha4 integrin, Journal of cellular biochemistry, vol.114, 2013.

F. Madeira, Y. M. Park, J. Lee, N. Buso, T. Gur et al., The EMBL-EBI search and sequence analysis tools APIs in 2019, Nucleic Acids Res, vol.47, pp.636-641, 2019.

S. Makino, K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri et al., Breeding of a non-obese, diabetic strain of mice, Jikken Dobutsu, vol.29, pp.1-13, 1980.

R. Marciano, G. D'annunzio, N. Minuto, L. Pasquali, A. Santamaria et al., Association of alleles at polymorphic sites in the Osteopontin encoding gene in young type 1 diabetic patients, Clin Immunol, vol.131, pp.84-91, 2009.

E. Melanitou, D. Devendra, E. Liu, D. Miao, and G. S. Eisenbarth, Early and quantal (by litter) expression of insulin autoantibodies in the nonobese diabetic mice predict early diabetes onset, J Immunol, vol.173, 2004.
URL : https://hal.archives-ouvertes.fr/pasteur-01643749

E. Melanitou, P. Fain, and G. S. Eisenbarth, Genetics of type 1A (immune mediated) diabetes, J Autoimmun, vol.21, pp.93-98, 2003.
URL : https://hal.archives-ouvertes.fr/pasteur-01643793

E. Melanitou, F. Joly, M. Lathrop, C. Boitard, and P. Avner, Evidence for the presence of insulindependent diabetes-associated alleles on the distal part of mouse chromosome 6, Genome Res, vol.8, 1998.

A. O'regan and J. S. Berman, Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation, International journal of experimental pathology, vol.81, pp.373-390, 2000.

A. W. O'regan, J. M. Hayden, and J. S. Berman, Osteopontin augments CD3-mediated interferongamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells, J Leukoc Biol, vol.68, pp.495-502, 2000.

A. W. O'regan, G. J. Nau, G. L. Chupp, and J. S. Berman, Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks, Immunol Today, vol.21, pp.475-478, 2000.

M. Ono, T. Yamamoto, and M. Nose, Allelic difference in the nucleotide sequence of the Eta-1/Op gene transcript, Mol Immunol, vol.32, pp.447-448, 1995.

G. Platzer, A. Schedlbauer, A. Chemelli, P. Ozdowy, N. Coudevylle et al., The metastasis-associated extracellular matrix protein osteopontin forms transient structure in ligand interaction sites, Biochemistry, vol.50, pp.6113-6124, 2011.

F. Ramsdell and S. F. Ziegler, Transcription factors in autoimmunity, Curr Opin Immunol, vol.15, 2003.

J. C. Reed and K. C. Herold, Thinking bedside at the bench: the NOD mouse model of T1DM, Nature reviews. Endocrinology, vol.11, pp.308-314, 2015.

B. Regnault, Y. F. Osorio, D. Miao, G. Eisenbarth, and E. Melanitou, Early over expression of messenger RNA for multiple genes, including insulin, in the Pancreatic Lymph Nodes of NOD mice is associated with Islet Autoimmunity, BMC medical genomics, vol.2, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-01643691

W. M. Ridgway, H. Ito, M. Fasso, C. Yu, and C. G. Fathman, Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response, J Exp Med, vol.188, 1998.

S. R. Rittling and R. Singh, Osteopontin in Immune-mediated Diseases, Journal of dental research, vol.94, pp.1638-1645, 2015.

M. D. Rosenblum, K. A. Remedios, and A. K. Abbas, Mechanisms of human autoimmunity, J Clin Invest, vol.125, pp.2228-2233, 2015.

V. Sampayo-escobar, R. Green, M. B. Cheung, R. Bedi, S. Mohapatra et al., Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection, PloS one, vol.13, 2018.

M. Scatena, M. Almeida, M. L. Chaisson, N. Fausto, R. F. Nicosia et al., NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival, The Journal of cell biology, vol.141, pp.1083-1093, 1998.

M. Scatena, L. Liaw, and C. M. Giachelli, Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arteriosclerosis, thrombosis, and vascular biology, vol.27, pp.2302-2309, 2007.

M. L. Shinohara, M. Jansson, E. S. Hwang, M. B. Werneck, L. H. Glimcher et al., T-betdependent expression of osteopontin contributes to T cell polarization, Proc Natl Acad Sci U S A, vol.102, pp.17101-17106, 2005.

M. L. Shinohara, H. J. Kim, J. H. Kim, V. A. Garcia, and H. Cantor, Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells, Proc Natl Acad Sci U S A, vol.105, 2008.

M. L. Shinohara, J. H. Kim, V. A. Garcia, and H. Cantor, Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin, Immunity, vol.29, pp.68-78, 2008.

M. L. Shinohara, L. Lu, J. Bu, M. B. Werneck, K. S. Kobayashi et al., Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells, Nat Immunol, vol.7, pp.498-506, 2006.

F. Sievers, A. Wilm, D. Dineen, T. J. Gibson, K. Karplus et al., Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega, p.539, 2011.

A. Slavin, C. Ewing, J. Liu, M. Ichikawa, J. Slavin et al., Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein, Autoimmunity, vol.28, pp.109-120, 1998.

M. A. Talat, L. M. Sherief, H. F. El-saadany, A. A. Rass, R. M. Saleh et al., The Role of Osteopontin in the Pathogenesis and Complications of Type 1 Diabetes Mellitus in Children, Journal of clinical research in pediatric endocrinology, vol.8, pp.399-404, 2016.

P. J. Thompson, A. Shah, V. Ntranos, F. Van-gool, M. Atkinson et al., Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes, Cell Metab, vol.29, 2019.

T. Trivedi, B. S. Franek, S. L. Green, S. N. Kariuki, M. Kumabe et al., Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus, Journal of biomedicine & biotechnology, p.802581, 2011.

K. X. Wang and D. T. Denhardt, Osteopontin: role in immune regulation and stress responses, Cytokine Growth Factor Rev, vol.19, pp.333-345, 2008.

G. F. Weber, S. Zawaideh, S. Hikita, V. A. Kumar, H. Cantor et al., Phosphorylationdependent interaction of osteopontin with its receptors regulates macrophage migration and activation, J Leukoc Biol, vol.72, pp.752-761, 2002.

A. Wendt, I. G. Mollet, A. Knutsson, V. S. Bolmgren, A. Hultgardh-nilsson et al., Osteopontin Affects Insulin Vesicle Localization and Ca2+ Homeostasis in Pancreatic Beta Cells from Female Mice, PloS one, vol.12, 2017.

L. S. Wicker, M. C. Appel, F. Dotta, A. Pressey, B. J. Miller et al., Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes, J Exp Med, vol.176, pp.67-77, 1992.

L. S. Wicker, J. A. Todd, and L. B. Peterson, Genetic control of autoimmune diabetes in the NOD mouse, Annu Rev Immunol, vol.13, pp.179-200, 1995.

L. Wirestam, M. Frodlund, H. Enocsson, T. Skogh, J. Wettero et al., Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE. Lupus science & medicine 4, 2017.

C. K. Wong, L. C. Lit, L. S. Tam, E. K. Li, and C. W. Lam, Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus, Rheumatology (Oxford), vol.44, pp.602-606, 2005.

R. P. Wuthrich, The complex role of osteopontin in renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association -European Renal Association, vol.13, 1998.

Y. Xie, M. Sakatsume, S. Nishi, I. Narita, M. Arakawa et al., Expression, roles, receptors, and regulation of osteopontin in the kidney, Kidney international, vol.60, pp.1645-1657, 2001.

B. Zhu, K. Suzuki, H. A. Goldberg, S. R. Rittling, D. T. Denhardt et al., Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through Gprotein-coupled receptors: evidence of a role for an intracellular form of osteopontin, Journal of cellular physiology, vol.198, pp.155-167, 2004.